{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T10:59:23Z","timestamp":1791284363811,"version":"4.1.0"},"reference-count":180,"publisher":"Frontiers Media SA","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Front. Oncol."],"DOI":"10.3389\/fonc.2014.00126","type":"journal-article","created":{"date-parts":[[2014,7,21]],"date-time":"2014-07-21T06:48:30Z","timestamp":1405925310000},"source":"Crossref","is-referenced-by-count":131,"title":["Emerging Insights into Barriers to Effective Brain Tumor Therapeutics"],"prefix":"10.3389","volume":"4","author":[{"given":"Graeme F.","family":"Woodworth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin P.","family":"Dunn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Nance","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Hanes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Brem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2014,7,21]]},"reference":[{"issue":"1","key":"B1","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3322\/caac.21208","article-title":"Cancer statistics, 2014","volume":"64","author":"Siegel","year":"2014","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"B2","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1093\/neuonc\/nop066","article-title":"Prevalence estimates for primary brain tumors in the United States by age, gender, behavior, and histology","volume":"12","author":"Porter","year":"2010","journal-title":"Neuro Oncol"},{"issue":"4","key":"B3","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/S0733-8619(18)31005-3","article-title":"Pathologic analysis of primary brain tumors","volume":"3","author":"McComb","year":"1985","journal-title":"Neurol Clin"},{"issue":"6","key":"B4","first-page":"969","article-title":"Systematic evaluation of primary brain tumors","volume":"31","author":"Gruber","year":"1990","journal-title":"J Nucl Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1001\/jama.1928.02690380007003","article-title":"Removal of right cerebral hemisphere for certain tumors with hemiplegia","volume":"90","author":"Dandy","year":"1928","journal-title":"J Am Med Assoc"},{"key":"B6","doi-asserted-by":"publisher","first-page":"636","DOI":"10.3171\/jns.1961.18.5.0636","article-title":"The growth of glioblastoma multiforme (astrocytomas, grades 3 and 4) in neurosurgical practice","volume":"18","author":"Matsukado","year":"1961","journal-title":"J Neurosurg"},{"issue":"1","key":"B7","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1021\/cc9800071","article-title":"A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases","volume":"1","author":"Ghose","year":"1999","journal-title":"J Comb Chem"},{"issue":"1","key":"B8","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1602\/neurorx.2.1.3","article-title":"The blood-brain barrier: bottleneck in brain drug development","volume":"2","author":"Pardridge","year":"2005","journal-title":"NeuroRx"},{"issue":"1","key":"B9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0006-8993(88)90577-X","article-title":"Kinetics and distribution volumes for tracers of different sizes in the brain plasma space","volume":"462","author":"Smith","year":"1988","journal-title":"Brain Res"},{"issue":"1","key":"B10","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/sj.jcbfm.9600315","article-title":"Efflux of drugs and solutes from brain: the interactive roles of diffusional transcapillary transport, bulk flow and capillary transporters","volume":"27","author":"Groothuis","year":"2007","journal-title":"J Cereb Blood Flow Metab"},{"issue":"2","key":"B11","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/0006-8993(91)90012-K","article-title":"Extravasation of staphylococcal alpha-toxin in normal and injured CNS regions lacking blood-brain barrier function: observations after ventral root replantation","volume":"559","author":"Sjogren","year":"1991","journal-title":"Brain Res"},{"issue":"3","key":"B12","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/0022-510X(70)90151-6","article-title":"The blood-brain barrier to proteins under normal and pathological conditions","volume":"10","author":"Brightman","year":"1970","journal-title":"J Neurol Sci"},{"issue":"6","key":"B13","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1227\/00006123-198006000-00014","article-title":"Blood-brain barrier: a definition of normal and altered function","volume":"6","author":"Pollay","year":"1980","journal-title":"Neurosurgery"},{"issue":"12 Pt 1","key":"B14","first-page":"6387","article-title":"A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs","volume":"46","author":"Matsumura","year":"1986","journal-title":"Cancer Res"},{"issue":"11","key":"B15","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1038\/nrclinonc.2010.139","article-title":"Delivering nanomedicine to solid tumors","volume":"7","author":"Jain","year":"2010","journal-title":"Nat Rev Clin Oncol"},{"issue":"4","key":"B16","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1111\/j.1750-3639.1992.tb00703.x","article-title":"Drainage of brain extracellular fluid into blood and deep cervical lymph and its immunological significance","volume":"2","author":"Cserr","year":"1992","journal-title":"Brain Pathol"},{"issue":"5","key":"B17","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1056\/NEJMra0708126","article-title":"Malignant gliomas in adults","volume":"359","author":"Wen","year":"2008","journal-title":"N Engl J Med"},{"issue":"5","key":"B18","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1073\/pnas.1018154108","article-title":"Scaling rules for diffusive drug delivery in tumor and normal tissues","volume":"108","author":"Baish","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"B19","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1073\/pnas.1018382108","article-title":"Multistage nanoparticle delivery system for deep penetration into tumor tissue","volume":"108","author":"Wong","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"B20","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1152\/physrev.00027.2007","article-title":"Diffusion in brain extracellular space","volume":"88","author":"Sykova","year":"2008","journal-title":"Physiol Rev"},{"issue":"4","key":"B21","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.neuint.2003.11.006","article-title":"Evidence for bulk flow of brain interstitial fluid: significance for physiology and pathology","volume":"45","author":"Abbott","year":"2004","journal-title":"Neurochem Int"},{"issue":"6","key":"B22","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1016\/j.mehy.2011.02.043","article-title":"New understanding of the role of cerebrospinal fluid: offsetting of arterial and brain pulsation and self-dissipation of cerebrospinal fluid pulsatile flow energy","volume":"76","author":"Min","year":"2011","journal-title":"Med Hypotheses"},{"issue":"4","key":"B23","first-page":"277","article-title":"The genesis of peritumoral vasogenic brain edema and tumor cysts: a hypothetical role for tumor-derived vascular permeability factor","volume":"66","author":"Criscuolo","year":"1993","journal-title":"Yale J Biol Med"},{"issue":"4","key":"B24","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/nrclinonc.2009.14","article-title":"VEGF inhibitors in the treatment of cerebral edema in patients with brain cancer","volume":"6","author":"Gerstner","year":"2009","journal-title":"Nat Rev Clin Oncol"},{"issue":"2","key":"B25","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1097\/00006123-199808000-00027","article-title":"Regional cerebral blood flow in peritumoral brain edema during dexamethasone treatment: a xenon-enhanced computed tomographic study","volume":"43","author":"Behrens","year":"1998","journal-title":"Neurosurgery"},{"issue":"147","key":"B26","doi-asserted-by":"publisher","first-page":"147ra11","DOI":"10.1126\/scitranslmed.3003748","article-title":"A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid beta","volume":"4","author":"Iliff","year":"2012","journal-title":"Sci Transl Med"},{"issue":"1","key":"B27","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1002\/glia.10204","article-title":"Diffusion parameters of the extracellular space in human gliomas","volume":"42","author":"Vargova","year":"2003","journal-title":"Glia"},{"issue":"3","key":"B28","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1096\/fj.04-2834fje","article-title":"Enhanced macromolecular diffusion in brain extracellular space in mouse models of vasogenic edema measured by cortical surface photobleaching","volume":"19","author":"Papadopoulos","year":"2005","journal-title":"FASEB J"},{"issue":"2","key":"B29","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s11060-004-2751-6","article-title":"Molecular mechanisms of glioma cell migration and invasion","volume":"70","author":"Demuth","year":"2004","journal-title":"J Neurooncol"},{"issue":"11","key":"B30","doi-asserted-by":"publisher","first-page":"3697","DOI":"10.1158\/1078-0432.CCR-08-2042","article-title":"Molecular mechanisms underlying effects of epidermal growth factor receptor inhibition on invasion, proliferation, and angiogenesis in experimental glioma","volume":"15","author":"Guillamo","year":"2009","journal-title":"Clin Cancer Res"},{"issue":"3","key":"B31","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1002\/ijc.10233","article-title":"Clinical impact and functional aspects of tenascin-C expression during glioma progression","volume":"98","author":"Herold-Mende","year":"2002","journal-title":"Int J Cancer"},{"issue":"10","key":"B32","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1097\/00005072-199910000-00001","article-title":"The extracellular matrix of gliomas: modulation of cell function","volume":"58","author":"Gladson","year":"1999","journal-title":"J Neuropathol Exp Neurol"},{"issue":"8","key":"B33","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1111\/j.1349-7006.2009.01189.x","article-title":"Endogenous tenascin-C enhances glioblastoma invasion with reactive change of surrounding brain tissue","volume":"100","author":"Hirata","year":"2009","journal-title":"Cancer Sci"},{"issue":"3","key":"B34","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1096\/fj.09-140491","article-title":"Tenascin-W is a specific marker of glioma-associated blood vessels and stimulates angiogenesis in vitro","volume":"24","author":"Martina","year":"2010","journal-title":"FASEB J"},{"issue":"1","key":"B35","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1385\/MN:29:1:61","article-title":"Ion channels and amino acid transporters support the growth and invasion of primary brain tumors","volume":"29","author":"Sontheimer","year":"2004","journal-title":"Mol Neurobiol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S0079-6123(00)25007-3","article-title":"Diffusion of molecules in brain extracellular space: theory and experiment","volume":"125","author":"Nicholson","year":"2000","journal-title":"Prog Brain Res"},{"key":"B37","first-page":"66","article-title":"Diffusion of anions and cations in the extracellular micro-environment of the brain [proceedings]","volume":"296","author":"Nicholson","year":"1979","journal-title":"J Physiol"},{"issue":"14","key":"B38","doi-asserted-by":"publisher","first-page":"5567","DOI":"10.1073\/pnas.0509425103","article-title":"In vivo diffusion analysis with quantum dots and dextrans predicts the width of brain extracellular space","volume":"103","author":"Thorne","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"B39","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1529\/biophysj.107.124743","article-title":"Diffusion of flexible random-coil dextran polymers measured in anisotropic brain extracellular space by integrative optical imaging","volume":"95","author":"Xiao","year":"2008","journal-title":"Biophys J"},{"issue":"149","key":"B40","doi-asserted-by":"publisher","first-page":"149ra19","DOI":"10.1126\/scitranslmed.3003594","article-title":"A dense poly(ethylene glycol) coating improves penetration of large polymeric nanoparticles within brain tissue","volume":"4","author":"Nance","year":"2012","journal-title":"Sci Transl Med"},{"issue":"3","key":"B41","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.ccr.2006.02.019","article-title":"Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis","volume":"9","author":"Phillips","year":"2006","journal-title":"Cancer Cell"},{"issue":"7216","key":"B42","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1038\/nature07385","article-title":"Comprehensive genomic characterization defines human glioblastoma genes and core pathways","volume":"455","author":"TCGA","year":"2008","journal-title":"Nature"},{"issue":"1","key":"B43","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ccr.2009.12.020","article-title":"Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1","volume":"17","author":"Verhaak","year":"2010","journal-title":"Cancer Cell"},{"issue":"2","key":"B44","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.cell.2013.09.034","article-title":"The somatic genomic landscape of glioblastoma","volume":"155","author":"Brennan","year":"2013","journal-title":"Cell"},{"issue":"2","key":"B45","doi-asserted-by":"publisher","first-page":"E9","DOI":"10.3171\/2012.12.FOCUS12349","article-title":"Molecular genetics of low-grade gliomas: genomic alterations guiding diagnosis and therapeutic intervention. 11th annual Frye-Halloran Brain Tumor Symposium","volume":"34","author":"Jones","year":"2013","journal-title":"Neurosurg Focus"},{"issue":"5897","key":"B46","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1126\/science.1164382","article-title":"An integrated genomic analysis of human glioblastoma multiforme","volume":"321","author":"Parsons","year":"2008","journal-title":"Science"},{"issue":"8","key":"B47","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1056\/NEJMoa0808710","article-title":"IDH1 and IDH2 mutations in gliomas","volume":"360","author":"Yan","year":"2009","journal-title":"N Engl J Med"},{"issue":"5848","key":"B48","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1126\/science.1142946","article-title":"Coactivation of receptor tyrosine kinases affects the response of tumor cells to targeted therapies","volume":"318","author":"Stommel","year":"2007","journal-title":"Science"},{"issue":"2","key":"B49","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/BF02484510","article-title":"Immunohistochemical analysis of the mutant epidermal growth factor, deltaEGFR, in glioblastoma","volume":"21","author":"Nishikawa","year":"2004","journal-title":"Brain Tumor Pathol"},{"issue":"6","key":"B50","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/j.ccr.2011.11.005","article-title":"Mosaic amplification of multiple receptor tyrosine kinase genes in glioblastoma","volume":"20","author":"Snuderl","year":"2011","journal-title":"Cancer Cell"},{"issue":"8","key":"B51","doi-asserted-by":"publisher","first-page":"3041","DOI":"10.1073\/pnas.1114033109","article-title":"Intratumoral heterogeneity of receptor tyrosine kinases EGFR and PDGFRA amplification in glioblastoma defines subpopulations with distinct growth factor response","volume":"109","author":"Szerlip","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7279","key":"B52","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1038\/nature08712","article-title":"The transcriptional network for mesenchymal transformation of brain tumours","volume":"463","author":"Carro","year":"2010","journal-title":"Nature"},{"issue":"17","key":"B53","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1038\/sj.onc.1201756","article-title":"PTEN mutations in gliomas and glioneuronal tumors","volume":"16","author":"Duerr","year":"1998","journal-title":"Oncogene"},{"issue":"5995","key":"B54","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/312649a0","article-title":"Cooperation between gene encoding p53 tumour antigen and ras in cellular transformation","volume":"312","author":"Parada","year":"1984","journal-title":"Nature"},{"issue":"6045","key":"B55","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1126\/science.1203619","article-title":"Mutational inactivation of STAG2 causes aneuploidy in human cancer","volume":"333","author":"Solomon","year":"2011","journal-title":"Science"},{"issue":"5","key":"B56","doi-asserted-by":"publisher","first-page":"e19868","DOI":"10.1371\/journal.pone.0019868","article-title":"Screen for IDH1, IDH2, IDH3, D2HGDH and L2HGDH mutations in glioblastoma","volume":"6","author":"Krell","year":"2011","journal-title":"PLoS One"},{"issue":"5","key":"B57","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/nrc2818","article-title":"Targeting brain cancer: advances in the molecular pathology of malignant glioma and medulloblastoma","volume":"10","author":"Huse","year":"2010","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"B58","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/sj.onc.1201544","article-title":"Genetic instability leads to loss of both p53 alleles in a human glioblastoma","volume":"16","author":"Albertoni","year":"1998","journal-title":"Oncogene"},{"issue":"10","key":"B59","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1056\/NEJMoa043331","article-title":"MGMT gene silencing and benefit from temozolomide in glioblastoma","volume":"352","author":"Hegi","year":"2005","journal-title":"N Engl J Med"},{"issue":"3","key":"B60","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1215\/15228517-2008-090","article-title":"Induction of MGMT expression is associated with temozolomide resistance in glioblastoma xenografts","volume":"11","author":"Kitange","year":"2009","journal-title":"Neuro Oncol"},{"issue":"2","key":"B61","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s11060-010-0395-2","article-title":"Quantitative analysis of O6-methylguanine DNA methyltransferase (MGMT) promoter methylation in patients with low-grade gliomas","volume":"103","author":"Ochsenbein","year":"2011","journal-title":"J Neurooncol"},{"issue":"31","key":"B62","doi-asserted-by":"publisher","first-page":"4722","DOI":"10.1200\/JCO.2010.28.6963","article-title":"Immunologic escape after prolonged progression-free survival with epidermal growth factor receptor variant III peptide vaccination in patients with newly diagnosed glioblastoma","volume":"28","author":"Sampson","year":"2010","journal-title":"J Clin Oncol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/1471-2164-9-54","article-title":"Glioma cells on the run \u00e2\u20ac\u201c the migratory transcriptome of 10 human glioma cell lines","volume":"9","author":"Demuth","year":"2008","journal-title":"BMC Genomics"},{"issue":"17","key":"B64","doi-asserted-by":"publisher","first-page":"5765","DOI":"10.1158\/1078-0432.CCR-11-0859","article-title":"Randomized phase II trial of Custirsen (OGX-011) in combination with docetaxel or mitoxantrone as second-line therapy in patients with metastatic castrate-resistant prostate cancer progressing after first-line docetaxel: CUOG trial P-06c","volume":"17","author":"Saad","year":"2011","journal-title":"Clin Cancer Res"},{"key":"B65","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1038\/bjc.2012.183","article-title":"A multicentre randomised phase II trial of gemcitabine alone vs gemcitabine and S-1 combination therapy in advanced pancreatic cancer: GEMSAP study","volume":"106","author":"Nakai","year":"2012","journal-title":"Br J Cancer"},{"issue":"8","key":"B66","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1111\/j.1349-7006.2012.02311.x","article-title":"Phase I trial of gemcitabine and candesartan combination therapy in normotensive patients with advanced pancreatic cancer: GECA1","volume":"103","author":"Nakai","year":"2012","journal-title":"Cancer Sci"},{"issue":"2","key":"B67","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.lungcan.2008.05.028","article-title":"An open phase II trial of gemcitabine, oxaliplatin and vinorelbine combination as first-line therapy in advanced non-small cell lung cancer patients","volume":"63","author":"Tredaniel","year":"2009","journal-title":"Lung Cancer"},{"issue":"1","key":"B68","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1097\/01.coc.0000139940.52625.d0","article-title":"A phase III trial evaluating the combination of cisplatin, etoposide, and radiation therapy with or without tamoxifen in patients with limited-stage small cell lung cancer: Cancer and Leukemia Group B Study (9235)","volume":"28","author":"McClay","year":"2005","journal-title":"Am J Clin Oncol"},{"issue":"2","key":"B69","doi-asserted-by":"publisher","first-page":"e30804","DOI":"10.1371\/journal.pone.0030804","article-title":"Parallel evolution under chemotherapy pressure in 29 breast cancer cell lines results in dissimilar mechanisms of resistance","volume":"7","author":"Tegze","year":"2012","journal-title":"PLoS One"},{"issue":"6","key":"B70","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1021\/mp200531m","article-title":"Evolution of drug resistance in cancer: the emergence of unique mechanisms and novel techniques","volume":"8","author":"Calcagno","year":"2011","journal-title":"Mol Pharm"},{"issue":"11","key":"B71","doi-asserted-by":"publisher","first-page":"e26100","DOI":"10.1371\/journal.pone.0026100","article-title":"Overlooking evolution: a systematic analysis of cancer relapse and therapeutic resistance research","volume":"6","author":"Aktipis","year":"2011","journal-title":"PLoS One"},{"issue":"3","key":"B72","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/S0167-8140(02)00078-6","article-title":"Radiotherapy for newly diagnosed malignant glioma in adults: a systematic review","volume":"64","author":"Laperriere","year":"2002","journal-title":"Radiother Oncol"},{"issue":"4","key":"B73","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1017\/S0317167100007265","article-title":"Adjuvant chemotherapy for adults with malignant glioma: a systematic review","volume":"34","author":"Perry","year":"2007","journal-title":"Can J Neurol Sci"},{"key":"B74","first-page":"46","article-title":"Use of dexamethasone in treatment of cerebral edema associated with brain tumors","volume":"81","author":"Galicich","year":"1961","journal-title":"J Lancet"},{"key":"B75","first-page":"169","article-title":"Use of dexamethasone in the treatment of cerebral edema resulting from brain tumors and brain surgery","volume":"12","author":"Galicich","year":"1961","journal-title":"Am Pract Dig Treat"},{"issue":"2","key":"B76","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.neulet.2008.12.047","article-title":"The molecular mechanism of dexamethasone-mediated effect on the blood-brain tumor barrier permeability in a rat brain tumor model","volume":"452","author":"Gu","year":"2009","journal-title":"Neurosci Lett"},{"issue":"2","key":"B77","doi-asserted-by":"publisher","first-page":"300","DOI":"10.3171\/jns.1999.90.2.0300","article-title":"Early changes measured by magnetic resonance imaging in cerebral blood flow, blood volume, and blood-brain barrier permeability following dexamethasone treatment in patients with brain tumors","volume":"90","author":"Ostergaard","year":"1999","journal-title":"J Neurosurg"},{"issue":"1","key":"B78","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/ana.410130107","article-title":"The effects of dexamethasone administration and withdrawal on water permeability across the blood-brain barrier","volume":"13","author":"Reid","year":"1983","journal-title":"Ann Neurol"},{"issue":"9311","key":"B79","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/S0140-6736(02)08091-1","article-title":"Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials","volume":"359","author":"Stewart","year":"2002","journal-title":"Lancet"},{"issue":"8956","key":"B80","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1016\/S0140-6736(95)90755-6","article-title":"Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. The Polymer-brain Tumor Treatment Group","volume":"345","author":"Brem","year":"1995","journal-title":"Lancet"},{"issue":"3","key":"B81","doi-asserted-by":"publisher","first-page":"333","DOI":"10.3171\/jns.1978.49.3.0333","article-title":"Evaluation of BCNU and\/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial","volume":"49","author":"Walker","year":"1978","journal-title":"J Neurosurg"},{"issue":"2","key":"B82","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1215\/15228517-5-2-79","article-title":"A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma","volume":"5","author":"Westphal","year":"2003","journal-title":"Neuro Oncol"},{"issue":"1","key":"B83","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1097\/00006123-199707000-00011","article-title":"Interstitial chemotherapy with carmustine-loaded polymers for high-grade gliomas: a randomized double-blind study","volume":"41","author":"Valtonen","year":"1997","journal-title":"Neurosurgery"},{"issue":"1","key":"B84","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1023\/A:1026286214901","article-title":"Combination fusion protein therapy of refractory brain tumors: demonstration of efficacy in cell culture","volume":"65","author":"Liu","year":"2003","journal-title":"J Neurooncol"},{"issue":"8","key":"B85","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1093\/neuonc\/nop054","article-title":"Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma","volume":"12","author":"Kunwar","year":"2010","journal-title":"Neuro Oncol"},{"issue":"2","key":"B86","doi-asserted-by":"publisher","first-page":"301","DOI":"10.3171\/2009.11.JNS091052","article-title":"Poor drug distribution as a possible explanation for the results of the PRECISE trial","volume":"113","author":"Sampson","year":"2010","journal-title":"J Neurosurg"},{"issue":"12","key":"B87","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1016\/j.biomaterials.2009.01.003","article-title":"Convection-enhanced delivery of nanocarriers for the treatment of brain tumors","volume":"30","author":"Allard","year":"2009","journal-title":"Biomaterials"},{"issue":"6","key":"B88","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1073\/pnas.91.6.2076","article-title":"Convection-enhanced delivery of macromolecules in the brain","volume":"91","author":"Bobo","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"B89","doi-asserted-by":"publisher","first-page":"893","DOI":"10.3171\/jns.2003.99.5.0893","article-title":"Safety and efficacy of convection-enhanced delivery of gemcitabine or carboplatin in a malignant glioma model in rats","volume":"99","author":"Degen","year":"2003","journal-title":"J Neurosurg"},{"issue":"6","key":"B90","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1097\/00006123-200012000-00026","article-title":"Tissue distribution and antitumor activity of topotecan delivered by intracerebral clysis in a rat glioma model","volume":"47","author":"Kaiser","year":"2000","journal-title":"Neurosurgery"},{"issue":"10","key":"B91","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N Engl J Med"},{"issue":"5","key":"B92","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1093\/neuonc\/nop063","article-title":"Cetuximab, bevacizumab, and irinotecan for patients with primary glioblastoma and progression after radiation therapy and temozolomide: a phase II trial","volume":"12","author":"Hasselbalch","year":"2010","journal-title":"Neuro Oncol"},{"issue":"28","key":"B93","doi-asserted-by":"publisher","first-page":"4733","DOI":"10.1200\/JCO.2008.19.8721","article-title":"Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma","volume":"27","author":"Friedman","year":"2009","journal-title":"J Clin Oncol"},{"issue":"2","key":"B94","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1084\/jem.141.2.427","article-title":"Inhibition of tumor angiogenesis mediated by cartilage","volume":"141","author":"Brem","year":"1975","journal-title":"J Exp Med"},{"issue":"0","key":"B95","first-page":"462","article-title":"Angiogenesis in brain tumors: a quantitative histologic study","volume":"25","author":"Brem","year":"1974","journal-title":"Surg Forum"},{"issue":"19","key":"B96","doi-asserted-by":"publisher","first-page":"6192","DOI":"10.1158\/1078-0432.CCR-10-1868","article-title":"Bevacizumab has differential and dose-dependent effects on glioma blood vessels and tumor cells","volume":"17","author":"von Baumgarten","year":"2011","journal-title":"Clin Cancer Res"},{"issue":"16","key":"B97","first-page":"4432","article-title":"Regional localization of a glioma-associated antigen defined by monoclonal antibody 81C6 in vivo: kinetics and implications for diagnosis and therapy","volume":"47","author":"Blasberg","year":"1987","journal-title":"Cancer Res"},{"issue":"1","key":"B98","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.wneu.2011.05.056","article-title":"Intra-arterial delivery of bevacizumab after blood-brain barrier disruption for the treatment of recurrent glioblastoma: progression-free survival and overall survival","volume":"77","author":"Burkhardt","year":"2012","journal-title":"World Neurosurg"},{"issue":"3","key":"B99","doi-asserted-by":"publisher","first-page":"624","DOI":"10.3171\/2010.9.JNS101223","article-title":"Safety and maximum tolerated dose of superselective intraarterial cerebral infusion of bevacizumab after osmotic blood-brain barrier disruption for recurrent malignant glioma. Clinical article","volume":"114","author":"Boockvar","year":"2011","journal-title":"J Neurosurg"},{"issue":"2","key":"B100","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1227\/NEU.0b013e3182314f9d","article-title":"Neurosurgical management and prognosis of patients with glioblastoma that progress during bevacizumab treatment","volume":"70","author":"Clark","year":"2011","journal-title":"Neurosurgery"},{"issue":"15","key":"B101","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1212\/WNL.0b013e3181d8a293","article-title":"Patterns of relapse and prognosis after bevacizumab failure in recurrent glioblastoma","volume":"74","author":"Chamberlain","year":"2010","journal-title":"Neurology"},{"issue":"15","key":"B102","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1212\/WNL.0b013e3181bc0184","article-title":"Patterns of relapse and prognosis after bevacizumab failure in recurrent glioblastoma","volume":"73","author":"Iwamoto","year":"2009","journal-title":"Neurology"},{"issue":"8","key":"B103","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1056\/NEJMoa1308573","article-title":"A randomized trial of bevacizumab for newly diagnosed glioblastoma","volume":"370","author":"Gilbert","year":"2014","journal-title":"N Engl J Med"},{"issue":"8","key":"B104","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1056\/NEJMoa1308345","article-title":"Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma","volume":"370","author":"Chinot","year":"2014","journal-title":"N Engl J Med"},{"issue":"3","key":"B105","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1023\/A:1012287212388","article-title":"High concentration of Daunorubicin and Daunorubicinol in human malignant astrocytomas after systemic administration of liposomal Daunorubicin","volume":"53","author":"Albrecht","year":"2001","journal-title":"J Neurooncol"},{"issue":"10","key":"B106","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1054\/bjoc.2000.1459","article-title":"High intratumoural accumulation of stealth liposomal doxorubicin (Caelyx) in glioblastomas and in metastatic brain tumours","volume":"83","author":"Koukourakis","year":"2000","journal-title":"Br J Cancer"},{"issue":"7","key":"B107","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1002\/1097-0142(20011001)92:71936::AID-CNCR17123.0.CO;2-H","article-title":"Long-term stabilization in patients with malignant glioma after treatment with liposomal doxorubicin","volume":"92","author":"Fabel","year":"2001","journal-title":"Cancer"},{"issue":"3","key":"B108","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1023\/A:1012098005098","article-title":"Delivery of loperamide across the blood-brain barrier with polysorbate 80-coated polybutylcyanoacrylate nanoparticles","volume":"14","author":"Alyautdin","year":"1997","journal-title":"Pharm Res"},{"issue":"10","key":"B109","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1023\/A:1018983904537","article-title":"Significant transport of doxorubicin into the brain with polysorbate 80-coated nanoparticles","volume":"16","author":"Gulyaev","year":"1999","journal-title":"Pharm Res"},{"issue":"14","key":"B110","doi-asserted-by":"publisher","first-page":"3652","DOI":"10.1158\/0008-5472.CAN-12-0128","article-title":"Temporary disruption of the blood-brain barrier by use of ultrasound and microbubbles: safety and efficacy evaluation in rhesus macaques","volume":"72","author":"McDannold","year":"2012","journal-title":"Cancer Res"},{"issue":"6","key":"B111","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.3171\/2010.11.JNS101201","article-title":"Inhibition of glioma growth by microbubble activation in a subcutaneous model using low duty cycle ultrasound without significant heating","volume":"114","author":"Burke","year":"2011","journal-title":"J Neurosurg"},{"issue":"46","key":"B112","doi-asserted-by":"publisher","DOI":"10.3791\/2145","article-title":"Contrast ultrasound targeted treatment of gliomas in mice via drug-bearing nanoparticle delivery and microvascular ablation","author":"Burke","year":"2010","journal-title":"J Vis Exp"},{"issue":"2","key":"B113","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1159\/000306139","article-title":"Acquired resistance to temozolomide in glioma cell lines: molecular mechanisms and potential translational applications","volume":"78","author":"Zhang","year":"2010","journal-title":"Oncology"},{"issue":"8","key":"B114","doi-asserted-by":"publisher","first-page":"582","DOI":"10.2176\/nmc.30.582","article-title":"Intra-arterial ACNU chemotherapy employing 20% mannitol osmotic blood-brain barrier disruption for malignant brain tumors","volume":"30","author":"Miyagami","year":"1990","journal-title":"Neurol Med Chir (Tokyo)"},{"issue":"1","key":"B115","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/2045-8118-9-10","article-title":"Blood-brain barrier disruption in CCL2 transgenic mice during pertussis toxin-induced brain inflammation","volume":"9","author":"Schellenberg","year":"2012","journal-title":"Fluids Barriers CNS"},{"issue":"10","key":"B116","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1038\/nm1651","article-title":"Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation","volume":"13","author":"Kebir","year":"2007","journal-title":"Nat Med"},{"issue":"4","key":"B117","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1215\/15228517-1-4-268","article-title":"Cereport (RMP-7) increases carboplatin levels in brain tumors after pretreatment with dexamethasone","volume":"1","author":"Dean","year":"1999","journal-title":"Neuro Oncol"},{"issue":"2","key":"B118","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1215\/15228517-5-2-96","article-title":"A randomized, double-blind, placebo-controlled, phase 2 study of RMP-7 in combination with carboplatin administered intravenously for the treatment of recurrent malignant glioma","volume":"5","author":"Prados","year":"2003","journal-title":"Neuro Oncol"},{"issue":"1","key":"B119","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1602\/neurorx.2.1.1","article-title":"The blood-brain barrier and neurotherapeutics","volume":"2","author":"Pardridge","year":"2005","journal-title":"NeuroRx"},{"issue":"7","key":"B120","doi-asserted-by":"publisher","first-page":"2820","DOI":"10.1073\/pnas.92.7.2820","article-title":"Transferrin-antibody fusion proteins are effective in brain targeting","volume":"92","author":"Shin","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"B121","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1667\/RR3361","article-title":"Radiation-induced up-regulation of adhesion molecules in brain microvasculature and their modulation by dexamethasone","volume":"163","author":"Yuan","year":"2005","journal-title":"Radiat Res"},{"issue":"4","key":"B122","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1089\/104303404322959498","article-title":"Normalization of striatal tyrosine hydroxylase and reversal of motor impairment in experimental parkinsonism with intravenous nonviral gene therapy and a brain-specific promoter","volume":"15","author":"Zhang","year":"2004","journal-title":"Hum Gene Ther"},{"issue":"84","key":"B123","doi-asserted-by":"publisher","first-page":"84ra44","DOI":"10.1126\/scitranslmed.3002230","article-title":"Boosting brain uptake of a therapeutic antibody by reducing its affinity for a transcytosis target","volume":"3","author":"Yu","year":"2011","journal-title":"Sci Transl Med"},{"issue":"2","key":"B124","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/nrd725","article-title":"Drug and gene targeting to the brain with molecular Trojan horses","volume":"1","author":"Pardridge","year":"2002","journal-title":"Nat Rev Drug Discov"},{"issue":"2","key":"B125","doi-asserted-by":"publisher","first-page":"90\u00e2\u20ac\u201c105,51","DOI":"10.1124\/mi.3.2.90","article-title":"Blood-brain barrier drug targeting: the future of brain drug development","volume":"3","author":"Pardridge","year":"2003","journal-title":"Mol Interv"},{"issue":"11","key":"B126","doi-asserted-by":"publisher","first-page":"6396","DOI":"10.1073\/pnas.101136398","article-title":"Oncolytic herpes simplex virus vector with enhanced MHC class I presentation and tumor cell killing","volume":"98","author":"Todo","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"B127","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1523\/JNEUROSCI.4905-07.2008","article-title":"Systemic vesicular stomatitis virus selectively destroys multifocal glioma and metastatic carcinoma in brain","volume":"28","author":"Ozduman","year":"2008","journal-title":"J Neurosci"},{"issue":"17","key":"B128","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1089\/104303400750038499","article-title":"A phase III clinical evaluation of herpes simplex virus type 1 thymidine kinase and ganciclovir gene therapy as an adjuvant to surgical resection and radiation in adults with previously untreated glioblastoma multiforme","volume":"11","author":"Rainov","year":"2000","journal-title":"Hum Gene Ther"},{"issue":"46","key":"B129","doi-asserted-by":"publisher","first-page":"20021","DOI":"10.1073\/pnas.1008261107","article-title":"Gene therapy-mediated delivery of targeted cytotoxins for glioma therapeutics","volume":"107","author":"Candolfi","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"B130","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1038\/mt.2009.184","article-title":"Molecular evolution of adeno-associated virus for enhanced glial gene delivery","volume":"17","author":"Koerber","year":"2009","journal-title":"Mol Ther"},{"issue":"3","key":"B131","first-page":"669","article-title":"Cytotoxicity and accumulation of ganciclovir triphosphate in bystander cells cocultured with herpes simplex virus type 1 thymidine kinase-expressing human glioblastoma cells","volume":"59","author":"Rubsam","year":"1999","journal-title":"Cancer Res"},{"issue":"23","key":"B132","doi-asserted-by":"publisher","first-page":"8932","DOI":"10.1158\/0008-5472.CAN-08-3873","article-title":"Human bone marrow-derived mesenchymal stem cells for intravascular delivery of oncolytic adenovirus Delta24-RGD to human gliomas","volume":"69","author":"Yong","year":"2009","journal-title":"Cancer Res"},{"issue":"5","key":"B133","doi-asserted-by":"publisher","first-page":"422","DOI":"10.2174\/156652309789753356","article-title":"Oncolytic adenovirus: preclinical and clinical studies in patients with human malignant gliomas","volume":"9","author":"Jiang","year":"2009","journal-title":"Curr Gene Ther"},{"issue":"26","key":"B134","doi-asserted-by":"publisher","first-page":"15155","DOI":"10.1073\/pnas.251543698","article-title":"Combination bacteriolytic therapy for the treatment of experimental tumors","volume":"98","author":"Dang","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"42","key":"B135","doi-asserted-by":"publisher","first-page":"15172","DOI":"10.1073\/pnas.0406242101","article-title":"Bacteriolytic therapy can generate a potent immune response against experimental tumors","volume":"101","author":"Agrawal","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"B136","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1158\/1078-0432.CCR-10-2563","article-title":"Gene expression profile correlates with T-cell infiltration and relative survival in glioblastoma patients vaccinated with dendritic cell immunotherapy","volume":"17","author":"Prins","year":"2011","journal-title":"Clin Cancer Res"},{"issue":"3","key":"B137","first-page":"842","article-title":"Vaccination of malignant glioma patients with peptide-pulsed dendritic cells elicits systemic cytotoxicity and intracranial T-cell infiltration","volume":"61","author":"Yu","year":"2001","journal-title":"Cancer Res"},{"issue":"14","key":"B138","doi-asserted-by":"publisher","first-page":"4973","DOI":"10.1158\/0008-5472.CAN-03-3505","article-title":"Vaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific, cytotoxic T-cells in patients with malignant glioma","volume":"64","author":"Yu","year":"2004","journal-title":"Cancer Res"},{"issue":"14","key":"B139","doi-asserted-by":"publisher","first-page":"5955","DOI":"10.1158\/0008-5472.CAN-07-5973","article-title":"Vaccination elicits correlated immune and clinical responses in glioblastoma multiforme patients","volume":"68","author":"Wheeler","year":"2008","journal-title":"Cancer Res"},{"issue":"5","key":"B140","doi-asserted-by":"publisher","first-page":"580","DOI":"10.2174\/156652409788488739","article-title":"STAT3 regulation of glioblastoma pathogenesis","volume":"9","author":"de la Iglesia","year":"2009","journal-title":"Curr Mol Med"},{"issue":"6","key":"B141","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1158\/1535-7163.MCT-11-0801","article-title":"STAT3 inhibition overcomes temozolomide resistance in glioblastoma by downregulating MGMT expression","volume":"11","author":"Kohsaka","year":"2012","journal-title":"Mol Cancer Ther"},{"issue":"55","key":"B142","doi-asserted-by":"publisher","first-page":"8404","DOI":"10.1038\/sj.onc.1206047","article-title":"Inhibition of constitutively active Stat3 suppresses proliferation and induces apoptosis in glioblastoma multiforme cells","volume":"21","author":"Rahaman","year":"2002","journal-title":"Oncogene"},{"key":"B143","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/gt.2011.82","article-title":"Targeted suicide gene therapy for glioma using human embryonic stem cell-derived neural stem cells genetically modified by baculoviral vectors","volume":"19","author":"Zhao","year":"2011","journal-title":"Gene Ther"},{"issue":"5","key":"B144","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1021\/mp200127u","article-title":"Glioma gene therapy using induced pluripotent stem cell derived neural stem cells","volume":"8","author":"Lee","year":"2011","journal-title":"Mol Pharm"},{"issue":"11","key":"B145","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1089\/hum.2010.212","article-title":"Human embryonic stem cell-derived mesenchymal stem cells as cellular delivery vehicles for prodrug gene therapy of glioblastoma","volume":"22","author":"Bak","year":"2011","journal-title":"Hum Gene Ther"},{"issue":"11","key":"B146","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1038\/sj.cgt.7700252","article-title":"Evaluation of combined vaccinia virus-mediated antitumor gene therapy with p53, IL-2, and IL-12 in a glioma model","volume":"7","author":"Chen","year":"2000","journal-title":"Cancer Gene Ther"},{"issue":"2","key":"B147","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s11060-006-9274-2","article-title":"Toll-like receptor triggered dendritic cell maturation and IL-12 secretion are necessary to overcome T-cell inhibition by glioma-associated TGF-beta2","volume":"82","author":"Grauer","year":"2007","journal-title":"J Neurooncol"},{"issue":"3A","key":"B148","first-page":"1337","article-title":"Antitumor effect of IL-2, p53, and bax gene transfer in C6 glioma cells","volume":"20","author":"Haghighat","year":"2000","journal-title":"Anticancer Res"},{"issue":"1","key":"B149","doi-asserted-by":"crossref","first-page":"260","DOI":"10.4049\/jimmunol.149.1.260","article-title":"Migration of recombinant IL-2-activated T and natural killer cells in the intercellular space of human H-2 glioma spheroids in vitro. A study on adhesion molecules involved","volume":"149","author":"Jaaskelainen","year":"1992","journal-title":"J Immunol"},{"issue":"3","key":"B150","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1023\/A:1023367223575","article-title":"Intracavitary VEGF, bFGF, IL-8, IL-12 levels in primary and recurrent malignant glioma","volume":"62","author":"Salmaggi","year":"2003","journal-title":"J Neurooncol"},{"issue":"4","key":"B151","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/BF00165710","article-title":"Pharmacokinetics of intraventricular administration","volume":"1","author":"Collins","year":"1983","journal-title":"J Neurooncol"},{"issue":"3","key":"B152","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.ejpn.2011.07.008","article-title":"Intrathecal baclofen for progressive neurological disease in childhood: a systematic review of literature","volume":"16","author":"Bonouvrie","year":"2012","journal-title":"Eur J Paediatr Neurol"},{"issue":"3","key":"B153","doi-asserted-by":"crossref","first-page":"219","DOI":"10.36076\/ppj.2011\/14\/219","article-title":"Intrathecal therapy for cancer and non-cancer pain","volume":"14","author":"Hayek","year":"2011","journal-title":"Pain Physician"},{"issue":"9","key":"B154","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/S1470-2045(06)70864-6","article-title":"Meningeal carcinomatosis from breast cancer treated with intrathecal trastuzumab","volume":"7","author":"Platini","year":"2006","journal-title":"Lancet Oncol"},{"issue":"2","key":"B155","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.critrevonc.2010.07.005","article-title":"Intrathecal chemotherapy in lymphomatous meningitis","volume":"79","author":"Canova","year":"2011","journal-title":"Crit Rev Oncol Hematol"},{"issue":"3","key":"B156","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.surneu.2007.07.040","article-title":"Preliminary results from a phase I\/II study of perillyl alcohol intranasal administration in adults with recurrent malignant gliomas","volume":"70","author":"da Fonseca","year":"2008","journal-title":"Surg Neurol"},{"issue":"5580","key":"B157","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1038\/263797a0","article-title":"Polymers for the sustained release of proteins and other macromolecules","volume":"263","author":"Langer","year":"1976","journal-title":"Nature"},{"issue":"13","key":"B158","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1016\/j.addr.2009.08.001","article-title":"Polymer therapeutics: clinical applications and challenges for development","volume":"61","author":"Vicent","year":"2009","journal-title":"Adv Drug Deliv Rev"},{"issue":"4","key":"B159","doi-asserted-by":"publisher","first-page":"640","DOI":"10.3171\/jns.1992.76.4.0640","article-title":"The intracerebral distribution of BCNU delivered by surgically implanted biodegradable polymers","volume":"76","author":"Grossman","year":"1992","journal-title":"J Neurosurg"},{"issue":"1\u00e2\u20ac\u201c3","key":"B160","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S0168-3659(01)00311-X","article-title":"Biodegradable polymer implants to treat brain tumors","volume":"74","author":"Brem","year":"2001","journal-title":"J Control Release"},{"issue":"8","key":"B161","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1080\/02652040802075799","article-title":"Three weeks release BCNU loaded hydrophilic-PLGA microspheres for interstitial chemotherapy: development and activity against human glioblastoma cells","volume":"25","author":"Esther Gil-Alegre","year":"2008","journal-title":"J Microencapsul"},{"issue":"6","key":"B162","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1023\/A:1012123127330","article-title":"In vitro\/in vivo comparison of drug release and polymer erosion from biodegradable P(FAD-SA) polyanhydrides \u00e2\u20ac\u201c a noninvasive approach by the combined use of electron paramagnetic resonance spectroscopy and nuclear magnetic resonance imaging","volume":"14","author":"Mader","year":"1997","journal-title":"Pharm Res"},{"issue":"2","key":"B163","doi-asserted-by":"publisher","first-page":"297","DOI":"10.3171\/jns.2003.99.2.0297","article-title":"An inflatable balloon catheter and liquid 125I radiation source (GliaSite Radiation Therapy System) for treatment of recurrent malignant glioma: multicenter safety and feasibility trial","volume":"99","author":"Tatter","year":"2003","journal-title":"J Neurosurg"},{"issue":"4","key":"B164","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1227\/01.NEU.0000194836.07848.69","article-title":"GliaSite brachytherapy for treatment of recurrent malignant gliomas: a retrospective multi-institutional analysis","volume":"58","author":"Gabayan","year":"2006","journal-title":"Neurosurgery"},{"issue":"4","key":"B165","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1016\/j.ijrobp.2004.12.032","article-title":"Treatment of recurrent glioblastoma multiforme with GliaSite brachytherapy","volume":"62","author":"Chan","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"33","key":"B166","doi-asserted-by":"publisher","first-page":"4947","DOI":"10.1016\/j.biomaterials.2007.06.011","article-title":"Active targeting of brain tumors using nanocarriers","volume":"28","author":"Beduneau","year":"2007","journal-title":"Biomaterials"},{"key":"B167","article-title":"Nanoparticle-based technologies for treating and imaging brain tumors","author":"Emerich","year":"2010","journal-title":"Curr Cancer Drug Targets"},{"issue":"6","key":"B168","doi-asserted-by":"publisher","first-page":"e11323","DOI":"10.1371\/journal.pone.0011323","article-title":"Specific visualization of glioma cells in living low-grade tumor tissue","volume":"5","author":"Kantelhardt","year":"2010","journal-title":"PLoS One"},{"issue":"4","key":"B169","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1021\/nl052405t","article-title":"Peptide-labeled near-infrared quantum dots for imaging tumor vasculature in living subjects","volume":"6","author":"Cai","year":"2006","journal-title":"Nano Lett"},{"issue":"3","key":"B170","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1080\/10717540490433895","article-title":"Colloidal gold: a novel nanoparticle vector for tumor directed drug delivery","volume":"11","author":"Paciotti","year":"2004","journal-title":"Drug Deliv"},{"issue":"2","key":"B171","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.jconrel.2012.03.026","article-title":"Therapeutics, imaging and toxicity of nanomaterials in the central nervous system","volume":"161","author":"Nunes","year":"2012","journal-title":"J Control Release"},{"issue":"7","key":"B172","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.addr.2012.01.004","article-title":"Challenges in drug delivery to tumors of the central nervous system: an overview of pharmacological and surgical considerations","volume":"64","author":"Serwer","year":"2012","journal-title":"Adv Drug Deliv Rev"},{"issue":"8","key":"B173","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3727\/000000006783980946","article-title":"TAT peptide-modified liposomes provide enhanced gene delivery to intracranial human brain tumor xenografts in nude mice","volume":"16","author":"Gupta","year":"2007","journal-title":"Oncol Res"},{"key":"B174","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/S0076-6879(09)65018-7","article-title":"Convection-enhanced delivery of liposomes to primate brain","volume":"465","author":"Krauze","year":"2009","journal-title":"Methods Enzymol"},{"issue":"2","key":"B175","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.ejpb.2009.09.003","article-title":"Drug delivery to the brain using surfactant-coated poly(lactide-co-glycolide) nanoparticles: influence of the formulation parameters","volume":"74","author":"Gelperina","year":"2010","journal-title":"Eur J Pharm Biopharm"},{"issue":"130","key":"B176","doi-asserted-by":"publisher","first-page":"130ra46","DOI":"10.1126\/scitranslmed.3003162","article-title":"Dendrimer-based postnatal therapy for neuroinflammation and cerebral palsy in a rabbit model","volume":"4","author":"Kannan","year":"2012","journal-title":"Sci Transl Med"},{"issue":"11","key":"B177","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1038\/nmat998","article-title":"Multi-pulse drug delivery from a resorbable polymeric microchip device","volume":"2","author":"Richards Grayson","year":"2003","journal-title":"Nat Mater"},{"issue":"2","key":"B178","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.jconrel.2007.08.003","article-title":"Resorbable polymer microchips releasing BCNU inhibit tumor growth in the rat 9L flank model","volume":"123","author":"Kim","year":"2007","journal-title":"J Control Release"},{"issue":"23","key":"B179","doi-asserted-by":"publisher","first-page":"5768","DOI":"10.1016\/j.biomaterials.2012.04.048","article-title":"Intracranial MEMS based temozolomide delivery in a 9L rat gliosarcoma model","volume":"33","author":"Masi","year":"2012","journal-title":"Biomaterials"},{"issue":"122","key":"B180","doi-asserted-by":"publisher","first-page":"122ra21","DOI":"10.1126\/scitranslmed.3003276","article-title":"First-in-human testing of a wirelessly controlled drug delivery microchip","volume":"4","author":"Farra","year":"2012","journal-title":"Sci Transl Med"}],"container-title":["Frontiers in Oncology"],"original-title":[],"deposited":{"date-parts":[[2023,7,15]],"date-time":"2023-07-15T06:50:40Z","timestamp":1689403840000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fonc.2014.00126\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,21]]},"references-count":180,"URL":"https:\/\/doi.org\/10.3389\/fonc.2014.00126","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,21]]}}}